Revenue: The sum of all revenue fields included for a company's operating activities.
Arcus Biosciences, Inc. (RCUS) had Revenue of $258.00M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$258.00M |
$-283.00M |
|
-- |
|
$258.00M |
|
$588.00M |
|
$-330.00M |
|
$48.00M |
|
$-282.00M |
|
$-282.00M |
|
$-283.00M |
|
$-283.00M |
|
$-283.00M |
|
$-283.00M |
|
$-330.00M |
|
$-345.00M |
|
90.10M |
|
90.10M |
|
$-3.14 |
|
$-3.14 |
|
| Balance Sheet Financials | |
$1.02B |
|
$47.00M |
|
$134.00M |
|
$1.15B |
|
$226.00M |
|
$48.00M |
|
$439.00M |
|
$665.00M |
|
$485.00M |
|
$485.00M |
|
$485.00M |
|
92.20M |
|
| Cash Flow Statement Financials | |
$-170.00M |
|
$-84.00M |
|
$277.00M |
|
$130.00M |
|
$153.00M |
|
$23.00M |
|
$76.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.50 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
100.00% |
|
-127.91% |
|
-127.91% |
|
-133.72% |
|
-109.30% |
|
-109.69% |
|
$-176.00M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
12.90 |
|
28.29 |
|
-58.35% |
|
-58.35% |
|
-24.61% |
|
-53.10% |
|
$5.26 |
|
$-1.95 |
|
$-1.89 |
|